Related references
Note: Only part of the references are listed.Angiotensin II type 1 receptor blockers: class effects versus molecular effects
Shin-ichiro Miura et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
IDENTIFICATION, SYNTHESIS AND STRUCTURAL DETERMINATION OF SOME IMPURITIES OF CANDESARTAN CILEXETIL
Jaroslav Havlicek et al.
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2009)
An update on non-peptide angiotensin receptor antagonists and related RAAS modulators
G. K. Aulakh et al.
LIFE SCIENCES (2007)
Feasibility of treating prehypertension with an angiotensin-receptor blocker
S Julius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The importance of impurity analysis in pharmaceutical products: an integrated approach
N Rahman et al.
ACCREDITATION AND QUALITY ASSURANCE (2006)
Share Paper
